Inverse associations between vitamin D status and risk of type 2 diabetes observed in epidemiological studies could be biased by confounding and reverse causality. We investigated the prospective association between vitamin D status and type 2 diabetes and the possible role of reverse causality.
Abstract

Aims
Inverse associations between vitamin D status and risk of type 2 diabetes observed in epidemiological studies could be biased by confounding and reverse causality. We investigated the prospective association between vitamin D status and type 2 diabetes and the possible role of reverse causality.
Methods
We conducted a case-cohort study within the Melbourne Collaborative Cohort Study (MCCS), including a random sample of 628 participants who developed diabetes and a sex- 
Introduction
Globally the prevalence of type 2 diabetes is increasing and if current trends continue, more than 642 million people (10% of adults) will have diabetes by 2040 [1] . Well-established risk factors for type 2 diabetes include excess body weight (particularly abdominal adiposity), physical inactivity, poor diet, increasing age, family history of type 2 diabetes, ethnicity, and genetics [1] . Identifying other risk factors could inform strategies for prevention.
Vitamin D has been linked to the pathogenesis of type 2 diabetes [2] [3] [4] [5] [6] [7] . Several metaanalyses of prospective studies have found an inverse association between vitamin D status, as assessed by circulating serum or plasma 25-hydroxyvitamin D (25(OH)D) concentrations, and risk of type 2 diabetes [8, 9] . However, these results have not been replicated in randomised controlled trials (RCTs) of vitamin D supplementation [10] , and a recent umbrella review of the literature pertaining to vitamin D and multiple health outcomes concluded that there was only suggestive evidence of an association between vitamin D and type 2 diabetes [11] . Existing RCTs have been criticised for design limitations such as lack of statistical power and inclusion of vitamin D replete individuals [12, 13] , while results from observational studies could be biased by confounding and reverse causality. Confounding is possible because vitamin D status is associated with several risk factors for diabetes (such as obesity, physical inactivity, age and ethnicity). Reverse causality would occur if study participants were in poor health at study entry due to undiagnosed diabetes, and this led to poor vitamin D status (for example via reduced sun exposure, dietary changes, or increased inflammation). Existing prospective cohort studies have not extensively explored the possibility of reverse causality, engendering uncertainty regarding any potential benefit of vitamin D for the prevention of type 2 diabetes.
We investigated the association between vitamin D status and the risk of type 2 diabetes in a large population-based prospective cohort study and examined whether this association is likely to be explained by reverse causality.
Subjects, Materials and Methods
A case-cohort study to investigate vitamin D status and the risk of cancer, type 2 diabetes and mortality was conducted within the Melbourne Collaborative Cohort Study (MCCS). The MCCS is a prospective cohort study of 41,514 participants (24,469 women and 17,045 men) living in the Melbourne metropolitan area who were predominantly aged between 40 and 69 years at study recruitment (1990) (1991) (1992) (1993) (1994) . Southern European migrants were deliberately recruited (approximately 25% of the cohort) to extend the range of dietary and lifestyle exposures. Details of the MCCS have been published [14] . Briefly, at baseline (wave 1) extensive demographic, lifestyle and dietary data were collected, and anthropometric measurements were performed. Participants were also asked whether they had ever been diagnosed with diabetes mellitus. Blood samples were collected, from which plasma glucose concentrations (67% fasting) were measured using Kodak Ektachem DT60 desktop analysers (Rochester, NY). From one year into study recruitment (for approximately 75% of participants), whole blood was spotted onto Guthrie cards, which were air dried and stored in dark conditions. Approximately four years after baseline (wave 2), participants were mailed a selfadministered questionnaire which asked about non-fatal and non-cancer health events, including diabetes. For self-reported incident cases of diabetes, 76% were confirmed by their GP as having type 2 diabetes [15] . Participants were also asked: "In general, would you say your health is: excellent, very good, good, fair, or poor?". A third wave of data collection was conducted between 2003 and 2007, when participants attended a clinic where further questionnaires were completed, anthropometric measurements, medication use (including insulin and oral hypoglycemics), and several disease endpoints were recorded, and another blood sample was collected. Plasma glucose concentrations were measured using a glucometer. Self-reported diabetes status and year of diagnosis were also recorded.
The Cancer Council Victoria's Human Research Ethics Committee approved the study protocol and participants gave written consent to participate.
Participants
Eligibility for the case-cohort study was restricted to the 29,206 participants who had no cancer diagnosis before baseline and for whom dried blood spots were available from baseline blood samples. For the diabetes component, we excluded 132 people with preexisting diabetes or unknown diabetes status at baseline, where diabetes status was determined from self-report or plasma glucose concentrations (see Table 1 ), leaving 29,074 eligible.
The diabetes study included a random sample of participants who developed diabetes between baseline and wave 3, and a sex-stratified random sample of all eligible participants ('subcohort'). Participants for whom 25(OH)D measurements were not performed, with missing data for any confounding variable, or with extreme total energy intakes (<1 st and >99 th sex-specific percentiles) were excluded. Participants with missing data on diabetes status were excluded from analyses because their case status was unknown. variation, which was removed using trigonometric regression [17] . Concentrations of 25(OH)D are reported as plasma equivalents, obtained using a previously developed calibration equation [18] . Participants were divided into sex-specific quartiles based on the distribution of batch-and season-adjusted plasma 25(OH)D for the subcohort.
Assessment of vitamin D status
Ascertainment of diabetes cases
Diabetes status was assessed at baseline, wave 2 and wave 3 using the criteria shown in Table   1 . On each occasion, participants who satisfied any of the criteria were classified as having diabetes, while those with incomplete information were classified as having missing diabetes status. The World Health Organization diagnostic criteria for plasma glucose concentrations indicative of diabetes were used [19] . No distinction between type 1 and type 2 diabetes was made, however, all incident cases were assumed to be type 2 because this is most likely after the age of 40 years [15, 20] . Classification of diabetes status at wave 3 used the same criteria as at baseline, except that where diabetes status was missing, participants using any diabetes medication were classified as a case, while those who did not report using any diabetes medications were considered not to have diabetes. A participant was classified as an incident case if they did not have diabetes at baseline and were identified as a case at either wave 2 or wave 3.
Confounders
The following confounding variables measured at baseline were included in analyses based 
Statistical analyses
Statistical analyses were performed using Stata version 14.1 (StataCorp, College Station, Texas, USA).
In light of the unconventional design of this study, with ascertainment of case status at two time points, there was no established strategy to use for analysing the data. Two strategies were explored, with no material difference in their results.
All results presented are from an analysis strategy that resembled a nested case-control study with density sampling. Three controls per case were selected (without replacement) at the same time as cases were identified and matched on sex. The flow diagram of participants included in the main analyses and their case status at each wave is shown in Figure 1 . There were 83 women and 77 men (total 160) with diabetes at wave 2. A random sample of 249 female and 231 male controls (total 480) was selected from the 2,391 subcohort participants who completed the wave 2 questionnaire and did not have diabetes at wave 2 (regardless of whether they later developed diabetes). There were 231 women and 237 men (total 468) with incident diabetes identified at wave 3 (i.e. who were not cases at wave 2). A sample of 693 female and 711 male controls (total 1,404) was randomly selected from the 1,491 subcohort participants who were not selected as controls at wave 2, attended the wave 3 clinic, and had not developed diabetes before wave 3.
The alternative analysis strategy was based on a nested case-control study with selection of controls at the end of follow-up (sometimes referred to as cumulative sampling). Cases were all people with diabetes (randomly selected cases plus subcohort cases) regardless of when they were identified as having diabetes (at wave 2 or wave 3 
Interaction by time since baseline
An interaction was fitted between 25(OH)D and time since baseline, where time=0 for wave 2 cases and controls, and time=1 for wave 3 cases and controls. This analysis was designed to assess whether the association differed by time since baseline (using two time points as it was not possible to assess time continuously).
Effect modification by sex and baseline disease status
To explore possible effect modification by sex, an interaction was fitted between continuous 25(OH)D and sex. Effect modification by baseline disease status was assessed by fitting interactions between continuous 25(OH)D and history of hypertension and history of CVD.
Sensitivity analysis
To investigate potential reverse causality, a sensitivity analysis was performed restricted to the 2,281 participants who reported being in good, very good, or excellent health at wave 2 and who did not have diabetes at wave 2. Of these, 139 women and 159 men (total 298) had diabetes at wave 3. A random sample of 417 female and 477 male controls (total 894) was selected from subcohort participants who did not have diabetes at wave 3.
Results
Participants
Of the 3,408 participants selected for the diabetes case-cohort study, 25(OH)D measurements
were not performed for 13 participants, confounder data was missing for 17 participants, and 55 had extreme values for daily total energy intake. After exclusion of these participants, 3,323 were eligible for analysis. In total, 628 people with diabetes were included in the analyses, of whom 109 were in the subcohort and 519 were non-subcohort cases. Controls for the nested density-sampled case-control study (for which results are presented) comprised 480 subcohort participants who did not develop diabetes before wave 2 (eight of whom later developed diabetes), and a further 1,404 subcohort participants who were selected as controls at wave 3, as shown in Figure 1 . Characteristics of diabetes cases and these subcohort controls are shown in Table 2 .
Main results
The Table 1 ).
Interaction by time since baseline
The average time between baseline (wave 1) and wave 2 was 4.0 (SD, 0.4) years (maximum 6.8 years) and the average time between baseline and wave 3 was 11.4 (SD, 1.2) years
(maximum follow-up time=14.6 years). The ORs were similar for the two strata defined by follow-up period (Table 3) . For the quartile analysis, p for time interaction=0.69 and for the continuous analysis, p for time interaction=0.42.
Effect modification by sex and baseline disease status
There was no evidence that the association varied by sex (p for interaction=0.49). Strengths of this study include the prospective design, long follow-up, large number of cases, extensive data on potential confounders, and generalisability based on a broad age range and community-based recruitment. A major strength was the availability of data on general health status several years after blood samples were collected, which facilitated assessment of reverse causality. Limitations included the different methods used to assess diabetes status at each wave of follow-up, and that participants were not specifically asked whether they had type 1 or type 2 diabetes. Nevertheless, it is unlikely that participants developed type 1 diabetes during follow-up because this is usually diagnosed before the age of 40 years [20] . [23] , suggest that the association between 25(OH)D and diabetes is unlikely to be due to inadequate control for confounding, which might be expected to work the same way across the ethnic groups.
Despite consistent evidence from observational studies of an inverse association between 25(OH)D concentrations and incident type 2 diabetes [8, 9] , there is no evidence from RCTs to support a causal association [10] . A possible explanation for the null results from RCTs is that vitamin D sufficiency might need to be sustained over long periods to have any benefit.
It is also possible that vitamin D sufficiency might need to be maintained throughout the entire lifetime, and supplementation may not be able to reverse disease processes once they are initiated [13, 24] . The results from this study, in which the association did not markedly change over time, and was stronger for participants in good to excellent health some years [26] . Taken together, these findings suggest that reverse causality might explain the results from observational studies.
The possibility of reverse causality has been a limitation of existing observational studies investigating the association between vitamin D status and disease. This is of particular concern for an outcome such as diabetes, for which people can remain asymptomatic and undiagnosed for years [1] . It is possible that lifestyle changes (e.g. in diet and outdoor activity) or suboptimal health prior to diagnosis, for example increased inflammation [27] , or hyperglycaemia causing tissue damage in undiagnosed diabetes, could provoke a reduction in 25(OH)D concentrations. If the association was due to reverse causality then a much stronger association would be expected to be observed in the first few years of follow-up. In the MCCS, the association at wave 2 (approximately 4 years after baseline) was similar to the association at wave 3 (approximately 11 years after baseline). The persistence of the association over time suggests that reverse causality is an unlikely explanation for the association observed in this study. However, due to the limited number of cases at wave 2 (n=160), any potential interaction with time could not be explored in depth. The sensitivity analysis restricted to participants who reported being in good to excellent health permitted a more thorough exploration of whether reverse causality could explain the observed association. The association was slightly stronger for participants who were in good/very good/excellent health approximately 4 years after baseline. For these participants, the risk of . Vitamin D is also thought to influence insulin secretion via extracellular and intracellular calcium levels, which govern release of insulin from beta cells [2, 3, 29, 34] . Tissues involved in the development of type 2 diabetes, such as adipose tissue and skeletal muscle, have VDRs, and locally-produced 1,25(OH) 2 D 3 in these tissues increases insulin sensitivity [7] . Vitamin D could also contribute to insulin sensitivity by regulating extracellular calcium, calcium influx, and intracellular calcium concentrations required for insulin-mediated functions such as glucose transport [2] . In addition, a vitamin D response element (VDRE) is present in the promoter region of the insulin receptor gene [35] , and 1,25(OH) 2 D 3 activates expression of this gene [36] . Consistent with experimental studies, observational studies have found an inverse association between 25(OH)D concentrations and insulin resistance [28, [37] [38] [39] . Finally, vitamin D could also indirectly contribute to the pathogenesis of type 2 diabetes via regulation of inflammatory processes (such as production of cytokines) associated with insulin resistance and beta cell death [2, 7, 40] .
Overall, a putative role of vitamin D in the aetiology of type 2 diabetes appears to be biologically plausible. In the MCCS, vitamin D status was inversely associated with the incidence of type 2 diabetes, and this association did not appear to be explained by reverse access to all the data in the study and had final responsibility for the decision to submit for publication. Ineligible: Pre-baseline cancer diagnosis or no dried blood spot samples n = 12,308
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